Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Viral protein kinases are enzymes encoded by viruses (notably large DNA viruses such as herpesviruses and poxviruses) that catalyze the transfer of a phosphate group from ATP to select serine, threonine, or tyrosine residues of protein substrates. Viral kinases (such as UL13, US3, UL97, U69, BGLF4, and ORF36) play crucial roles in the viral life cycle, including phosphorylation of both viral and host proteins to regulate DNA replication, virion assembly, immune evasion, and cell cycle control. Several are targets of approved or experimental antiviral drugs and have roles in pathogenesis of infection-associated diseases, including certain cancers. The category "viral protein kinase" is generic and encompasses multiple specific enzymes, so more precise identification (e.g., "HCMV UL97 protein kinase") is preferred for structured pharmaceutical work.
Inhibition of viral protein kinases blocks phosphorylation events essential for viral replication and assembly Inhibition can disrupt activation/protection of viral or host cell proteins needed for virus survival
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Viral protein kinase.